e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Anti-infective treatment and resistance in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis
B. Garfield, G. Keir, M. Anwar, M. Loebinger, R. Wilson, E. Renzoni, A. Wells, T. Maher (London, United Kingdom)
Source:
Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Session:
Anti-infective treatment and resistance in respiratory infections
Session type:
Poster Discussion
Number:
4366
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Garfield, G. Keir, M. Anwar, M. Loebinger, R. Wilson, E. Renzoni, A. Wells, T. Maher (London, United Kingdom). Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 4366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015
Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Comparison of clinical characteristics of invasive tracheobronchial aspergillosis with or without invasive pulmonary aspergillosis
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011
Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients
Source: Eur Respir J 2001 Jan 01;19(4):743-755
Year: 2002
Surgery treatment of pulmonary aspergillosis
Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology
Year: 2007
Invasive pulmonary aspergillosis: What is the role of surgery in the voriconazole era?
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis
Source: Eur Respir J 2012; 40: 271-273
Year: 2012
Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
PET‘s importance in chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
A rare presentation of pulmonary aspergillosis: Bronchial stump aspergillosis
Source: International Congress 2019 – CCC Respiratory infections
Year: 2019
CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016
Year: 2017
Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
VATS-resection and lobectomy for invasive pulmonary aspergillosis in severely immunocompromised patients with hematologic diseases
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010
Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis
Source: Eur Respir J 2006; 28: 352-357
Year: 2006
Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG)
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005
Therapy of pulmonary aspergillosis with newly developed azole-derivatives
Source: Eur Respir J 2001; 18: Suppl. 33, 138s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept